{"transactions":[{"id":828983,"issuer":{"id":6405,"kind":"organization","name":"Blue Water Acquisition Corp. IV"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrants to purchase Class A ordinary shares","published_at":"2026-03-24T16:30:06.000Z","date":"2026-03-23","kind":"purchase","planned":false,"acquired":true,"shares":137500,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the 275,000 private units owned by Blue Water Acquisition IV LLC, the Issuer's sponsor (the \"sponsor\"). Each private unit consists of one Class A ordinary share and one-half of one warrant, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share for $11.50 per share, subject to adjustment. The private units were purchased at $10.00 per unit for an aggregate purchase price of $2,750,000. Joseph Hernandez is the managing member of the sponsor and has voting and dispositive power over the securities held of record by the sponsor. Mr. Hernandez disclaims any beneficial ownership of the securities held by the sponsor, except to the extent of his pecuniary interest therein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrants included in the private units will become exercisable at the later of 12 months from the closing of the Issuer's initial public offering and 30 days after the completion of its initial business combination and will expire five years after the completion of the initial business combination or earlier upon redemption or liquidation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The warrants included in the private units will become exercisable at the later of 12 months from the closing of the Issuer's initial public offering and 30 days after the completion of its initial business combination and will expire five years after the completion of the initial business combination or earlier upon redemption or liquidation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Reflects the 275,000 private units owned by Blue Water Acquisition IV LLC, the Issuer's sponsor (the \"sponsor\"). Each private unit consists of one Class A ordinary share and one-half of one warrant, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share for $11.50 per share, subject to adjustment. The private units were purchased at $10.00 per unit for an aggregate purchase price of $2,750,000. Joseph Hernandez is the managing member of the sponsor and has voting and dispositive power over the securities held of record by the sponsor. Mr. Hernandez disclaims any beneficial ownership of the securities held by the sponsor, except to the extent of his pecuniary interest therein."}],"balance_after":137500,"derivative":{"exercise_price":11.5,"underlying":"Class A ordinary shares","underlying_shares":137500},"source":{"system":"sec-edgar","filing":"0001493152-26-012371","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1598384/000149315226012371/ownership.xml","form_type":"4"}},{"id":828982,"issuer":{"id":6405,"kind":"organization","name":"Blue Water Acquisition Corp. IV"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A ordinary shares","published_at":"2026-03-24T16:30:06.000Z","date":"2026-03-23","kind":"purchase","planned":false,"acquired":true,"shares":275000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the 275,000 private units owned by Blue Water Acquisition IV LLC, the Issuer's sponsor (the \"sponsor\"). Each private unit consists of one Class A ordinary share and one-half of one warrant, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share for $11.50 per share, subject to adjustment. The private units were purchased at $10.00 per unit for an aggregate purchase price of $2,750,000. Joseph Hernandez is the managing member of the sponsor and has voting and dispositive power over the securities held of record by the sponsor. Mr. Hernandez disclaims any beneficial ownership of the securities held by the sponsor, except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Reflects the 275,000 private units owned by Blue Water Acquisition IV LLC, the Issuer's sponsor (the \"sponsor\"). Each private unit consists of one Class A ordinary share and one-half of one warrant, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share for $11.50 per share, subject to adjustment. The private units were purchased at $10.00 per unit for an aggregate purchase price of $2,750,000. Joseph Hernandez is the managing member of the sponsor and has voting and dispositive power over the securities held of record by the sponsor. Mr. Hernandez disclaims any beneficial ownership of the securities held by the sponsor, except to the extent of his pecuniary interest therein."}],"balance_after":275000,"source":{"system":"sec-edgar","filing":"0001493152-26-012371","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598384/000149315226012371/ownership.xml","form_type":"4"}},{"id":986294,"issuer":{"id":5827,"kind":"organization","name":"Blue Water Acquisition Corp. III"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrants to purchase Class A ordinary shares","published_at":"2025-11-28T22:05:04.000Z","date":"2025-11-25","kind":"other","planned":false,"acquired":false,"shares":215000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Represents securities included in the 430,000 Private Placement Units."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each whole Private Placement Warrant entitles the holder thereof to purchase one Class A ordinary share for $11.50 per share, subject to adjustment. The Private Placement Warrants will become exercisable at the later of 12 months from the closing of the Issuer's initial public offering and 30 days after the completion of its initial business combination and will expire five years after the completion of the initial business combination or earlier upon redemption or liquidation."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the Purchase Agreement, dated as of November 25, 2025, by and among the Issuer, Blue Water Acquisition III LLC (the \"Original Sponsor\") and Yorkville BW Acquisition Sponsor, LLC (the \"New Sponsor\"), the Original Sponsor sold to the New Sponsor an aggregate of 6,325,000 Class B ordinary shares (the \"Founder Shares\") and 430,000 private placement units (the \"Private Placement Units\"), consisting of 430,000 Class A ordinary shares and 215,000 warrants to purchase Class A ordinary shares of the Issuer (the \"Private Placement Warrants\"). The New Sponsor purchased the Founder Shares and Private Placement Units for an aggregate purchase price of $7,200,000."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each whole Private Placement Warrant entitles the holder thereof to purchase one Class A ordinary share for $11.50 per share, subject to adjustment. The Private Placement Warrants will become exercisable at the later of 12 months from the closing of the Issuer's initial public offering and 30 days after the completion of its initial business combination and will expire five years after the completion of the initial business combination or earlier upon redemption or liquidation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each whole Private Placement Warrant entitles the holder thereof to purchase one Class A ordinary share for $11.50 per share, subject to adjustment. The Private Placement Warrants will become exercisable at the later of 12 months from the closing of the Issuer's initial public offering and 30 days after the completion of its initial business combination and will expire five years after the completion of the initial business combination or earlier upon redemption or liquidation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by the Original Sponsor. The Reporting Person is a managing member of the Original Sponsor, therefore, he may be deemed to have beneficial ownership of the securities held directly by the Original Sponsor. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class A ordinary shares","underlying_shares":215000},"source":{"system":"sec-edgar","filing":"0001493152-25-025414","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2050501/000149315225025414/ownership.xml","form_type":"4"}},{"id":986293,"issuer":{"id":5827,"kind":"organization","name":"Blue Water Acquisition Corp. III"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B ordinary shares","published_at":"2025-11-28T22:05:04.000Z","date":"2025-11-25","kind":"other","planned":false,"acquired":false,"shares":6325000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Class B ordinary shares have no expiration date and will automatically convert into Class A ordinary shares at the time of the Issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the Purchase Agreement, dated as of November 25, 2025, by and among the Issuer, Blue Water Acquisition III LLC (the \"Original Sponsor\") and Yorkville BW Acquisition Sponsor, LLC (the \"New Sponsor\"), the Original Sponsor sold to the New Sponsor an aggregate of 6,325,000 Class B ordinary shares (the \"Founder Shares\") and 430,000 private placement units (the \"Private Placement Units\"), consisting of 430,000 Class A ordinary shares and 215,000 warrants to purchase Class A ordinary shares of the Issuer (the \"Private Placement Warrants\"). The New Sponsor purchased the Founder Shares and Private Placement Units for an aggregate purchase price of $7,200,000."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Class B ordinary shares have no expiration date and will automatically convert into Class A ordinary shares at the time of the Issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Class B ordinary shares have no expiration date and will automatically convert into Class A ordinary shares at the time of the Issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by the Original Sponsor. The Reporting Person is a managing member of the Original Sponsor, therefore, he may be deemed to have beneficial ownership of the securities held directly by the Original Sponsor. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":6325000},"source":{"system":"sec-edgar","filing":"0001493152-25-025414","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2050501/000149315225025414/ownership.xml","form_type":"4"}},{"id":986292,"issuer":{"id":5827,"kind":"organization","name":"Blue Water Acquisition Corp. III"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A ordinary shares","published_at":"2025-11-28T22:05:04.000Z","date":"2025-11-25","kind":"sale","planned":false,"acquired":false,"shares":430000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Represents securities included in the 430,000 Private Placement Units."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the Purchase Agreement, dated as of November 25, 2025, by and among the Issuer, Blue Water Acquisition III LLC (the \"Original Sponsor\") and Yorkville BW Acquisition Sponsor, LLC (the \"New Sponsor\"), the Original Sponsor sold to the New Sponsor an aggregate of 6,325,000 Class B ordinary shares (the \"Founder Shares\") and 430,000 private placement units (the \"Private Placement Units\"), consisting of 430,000 Class A ordinary shares and 215,000 warrants to purchase Class A ordinary shares of the Issuer (the \"Private Placement Warrants\"). The New Sponsor purchased the Founder Shares and Private Placement Units for an aggregate purchase price of $7,200,000."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by the Original Sponsor. The Reporting Person is a managing member of the Original Sponsor, therefore, he may be deemed to have beneficial ownership of the securities held directly by the Original Sponsor. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":430000,"source":{"system":"sec-edgar","filing":"0001493152-25-025414","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2050501/000149315225025414/ownership.xml","form_type":"4"}},{"id":1113843,"issuer":{"id":5827,"kind":"organization","name":"Blue Water Acquisition Corp. III"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrants to purchase Class A ordinary shares","published_at":"2025-06-12T20:27:44.000Z","date":"2025-06-11","kind":"purchase","planned":false,"acquired":true,"shares":215000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the 430,000 private units owned by Blue Water Acquisition III LLC, the Issuer's sponsor. Each private unit consists of one Class A ordinary share and one-half of one warrant, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share for $11.50 per share, subject to adjustment. The private units were purchased at $10.00 per unit for an aggregate purchase price of $4,300,000. Joseph Hernandez is the managing member of the sponsor and has voting and dispositive power over the securities held of record by the sponsor. Mr. Hernandez disclaims any beneficial ownership of the securities held by the sponsor, except to the extent of his pecuniary interest therein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrants included in the private units will become exercisable at the later of 12 months from the closing of the Issuer's initial public offering and 30 days after the completion of its initial business combination and will expire five years after the completion of the initial business combination or earlier upon redemption or liquidation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The warrants included in the private units will become exercisable at the later of 12 months from the closing of the Issuer's initial public offering and 30 days after the completion of its initial business combination and will expire five years after the completion of the initial business combination or earlier upon redemption or liquidation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Reflects the 430,000 private units owned by Blue Water Acquisition III LLC, the Issuer's sponsor. Each private unit consists of one Class A ordinary share and one-half of one warrant, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share for $11.50 per share, subject to adjustment. The private units were purchased at $10.00 per unit for an aggregate purchase price of $4,300,000. Joseph Hernandez is the managing member of the sponsor and has voting and dispositive power over the securities held of record by the sponsor. Mr. Hernandez disclaims any beneficial ownership of the securities held by the sponsor, except to the extent of his pecuniary interest therein."}],"balance_after":215000,"derivative":{"exercise_price":11.5,"underlying":"Class A ordinary shares","underlying_shares":215000},"source":{"system":"sec-edgar","filing":"0001641172-25-014857","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2050501/000164117225014857/ownership.xml","form_type":"4"}},{"id":1113842,"issuer":{"id":5827,"kind":"organization","name":"Blue Water Acquisition Corp. III"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A ordinary shares","published_at":"2025-06-12T20:27:44.000Z","date":"2025-06-11","kind":"purchase","planned":false,"acquired":true,"shares":430000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the 430,000 private units owned by Blue Water Acquisition III LLC, the Issuer's sponsor. Each private unit consists of one Class A ordinary share and one-half of one warrant, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share for $11.50 per share, subject to adjustment. The private units were purchased at $10.00 per unit for an aggregate purchase price of $4,300,000. Joseph Hernandez is the managing member of the sponsor and has voting and dispositive power over the securities held of record by the sponsor. Mr. Hernandez disclaims any beneficial ownership of the securities held by the sponsor, except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Reflects the 430,000 private units owned by Blue Water Acquisition III LLC, the Issuer's sponsor. Each private unit consists of one Class A ordinary share and one-half of one warrant, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share for $11.50 per share, subject to adjustment. The private units were purchased at $10.00 per unit for an aggregate purchase price of $4,300,000. Joseph Hernandez is the managing member of the sponsor and has voting and dispositive power over the securities held of record by the sponsor. Mr. Hernandez disclaims any beneficial ownership of the securities held by the sponsor, except to the extent of his pecuniary interest therein."}],"balance_after":430000,"source":{"system":"sec-edgar","filing":"0001641172-25-014857","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2050501/000164117225014857/ownership.xml","form_type":"4"}},{"id":1896374,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-05-11T21:22:57.000Z","date":"2023-05-09","kind":"grant","planned":false,"acquired":true,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock award was granted pursuant to the Blue Water Biotech, Inc. Amended and Restated 2022 Equity Incentive Plan. 50% of the stock award will vest on August 17, 2023; 25% of the award will vest on August 17, 2024; and the remaining 25% of the award will vest on August 18, 2025."}],"balance_after":2800351,"source":{"system":"sec-edgar","filing":"0001213900-23-038670","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598384/000121390023038670/ownership.xml","form_type":"4"}},{"id":2176713,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-08-22T21:59:52.000Z","date":"2022-08-22","kind":"sale","acquired":false,"shares":30269,"price":4.1034,"value":124205.8146,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Common Stock reported herein were sold by the reporting person at a high price of $4.22, a low price of $4.05 and an average price of $4.1034 per share of Common Stock. Upon request, the reporting person will provide details of each sale."}],"balance_after":2650351,"source":{"system":"sec-edgar","filing":"0001213900-22-050240","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1598384/000121390022050240/ownership.xml","form_type":"4"}},{"id":2176712,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-08-22T21:59:52.000Z","date":"2022-08-19","kind":"sale","acquired":false,"shares":76841,"price":4.2121,"value":323661.9761,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Common Stock reported herein were sold by the reporting person at a high price of $4.71, a low price of $4.05 and an average price of $4.2121 per share of Common Stock. Upon request, the reporting person will provide details of each sale."}],"balance_after":2680620,"source":{"system":"sec-edgar","filing":"0001213900-22-050240","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1598384/000121390022050240/ownership.xml","form_type":"4"}},{"id":2176711,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-08-22T21:59:52.000Z","date":"2022-08-18","kind":"sale","acquired":false,"shares":442539,"price":4.9551,"value":2192824.9989,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Common Stock reported herein were sold by the reporting person at a high price of $6.21, a low price of $4.16 and an average price of $4.9551 per share of Common Stock. Upon request, the reporting person will provide details of each sale."}],"balance_after":2757461,"source":{"system":"sec-edgar","filing":"0001213900-22-050240","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598384/000121390022050240/ownership.xml","form_type":"4"}},{"id":2237948,"issuer":{"id":126356,"kind":"organization","name":"Clarus Therapeutics Holdings, Inc.","symbol":"CRXT"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-09T20:02:36.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":4805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted under the 2021 Plan and vest in full at the earlier of June 7, 2023 or the next annual meeting subject to the Reporting Person having a service relationship as of each such vesting."}],"balance_after":4805,"derivative":{"exercise_price":0.4339,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":4805},"source":{"system":"sec-edgar","filing":"0000899243-22-021755","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1817944/000089924322021755/doc4.xml","form_type":"4"}},{"id":2237947,"issuer":{"id":126356,"kind":"organization","name":"Clarus Therapeutics Holdings, Inc.","symbol":"CRXT"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-09T20:02:36.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":1922,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted a Restricted Stock Unit under the Issuer's 2021 Stock Option and Incentive Plan (the \"2021 Plan\") for 1,922 shares on 06/07/2022, which vests in full at the earlier of June 7, 2023 or the next annual meeting subject to the Reporting Person having a service relationship as of each such vesting."}],"balance_after":1243266,"source":{"system":"sec-edgar","filing":"0000899243-22-021755","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817944/000089924322021755/doc4.xml","form_type":"4"}},{"id":2252737,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Stock Option","published_at":"2022-05-27T10:42:43.000Z","date":"2022-05-04","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options (the \"Options\") were granted to Mr. Hernandez on May 4, 2022. The Options vest and become exercisable as follows (i) 174,972 Options vested immediately upon grant; (ii) 4,171 Options vest at the end of each calendar month from the date of issuance through September 30, 2022 and (iii) the remaining 4,173 Options vest on October 30, 2022."}],"balance_after":200000,"derivative":{"exercise_price":6.45,"expiration_date":"2032-05-04","underlying":"Common Stock, par value $0.00001 per share","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001213900-22-029997","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598384/000121390022029997/ownership.xml","form_type":"4"}},{"id":2289739,"issuer":{"id":126356,"kind":"organization","name":"Clarus Therapeutics Holdings, Inc.","symbol":"CRXT"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2022-04-27T16:09:13.000Z","date":"2022-04-25","kind":"grant","acquired":true,"shares":3445000,"price":1,"value":3445000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the transfer of an aggregate of 1,237,500 shares of common stock and 3,445,000 warrants held by the Sponsor to Mr. Hernandez, pursuant to that certain share transfer agreement entered by and between the Sponsor and Mr. Hernandez. Mr. Hernandez will be the holder of record of these securities after the transfer."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F5","text":"The Sponsor acquired these warrants for a purchase price of $1.00 per warrant in connection with the initial public offering of the registrant. The warrants became eligible for exercise upon consummation of the registrant's initial business combination on September 9, 2021. Each whole warrant is exercisable to purchase one share of the registrant's common stock at an exercise price of $11.50."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The Sponsor acquired these warrants for a purchase price of $1.00 per warrant in connection with the initial public offering of the registrant. The warrants became eligible for exercise upon consummation of the registrant's initial business combination on September 9, 2021. Each whole warrant is exercisable to purchase one share of the registrant's common stock at an exercise price of $11.50."}],"balance_after":3445000,"derivative":{"exercise_price":11.5,"exercise_date":"2021-09-09","expiration_date":"2026-09-09","underlying":"Common Stock","underlying_shares":3445000},"source":{"system":"sec-edgar","filing":"0001213900-22-021910","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022021910/ownership.xml","form_type":"4"}},{"id":2289738,"issuer":{"id":126356,"kind":"organization","name":"Clarus Therapeutics Holdings, Inc.","symbol":"CRXT"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-27T16:09:13.000Z","date":"2022-04-25","kind":"other","acquired":true,"shares":1237500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the transfer of an aggregate of 1,237,500 shares of common stock and 3,445,000 warrants held by the Sponsor to Mr. Hernandez, pursuant to that certain share transfer agreement entered by and between the Sponsor and Mr. Hernandez. Mr. Hernandez will be the holder of record of these securities after the transfer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Represents shares of common stock held directly by Mr. Hernandez, including (1) 1,237,500 shares of common stock transferred from the Sponsor and (2) 3,844 shares of common stock underlying the Restricted Stock Unit granted to Mr. Hernandez under the Issuer's 2021 Stock Option and Incentive Plan (the \"2021 Plan\") on 12/12/2021, which vests in equal annual installments over three years from the date of grant subject to the Reporting Person having a service relationship as of each such vesting date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Represents the transfer of an aggregate of 1,237,500 shares of common stock and 3,445,000 warrants held by the Sponsor to Mr. Hernandez, pursuant to that certain share transfer agreement entered by and between the Sponsor and Mr. Hernandez. Mr. Hernandez will be the holder of record of these securities after the transfer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Represents shares of common stock held directly by Mr. Hernandez, including (1) 1,237,500 shares of common stock transferred from the Sponsor and (2) 3,844 shares of common stock underlying the Restricted Stock Unit granted to Mr. Hernandez under the Issuer's 2021 Stock Option and Incentive Plan (the \"2021 Plan\") on 12/12/2021, which vests in equal annual installments over three years from the date of grant subject to the Reporting Person having a service relationship as of each such vesting date."}],"balance_after":1241344,"source":{"system":"sec-edgar","filing":"0001213900-22-021910","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022021910/ownership.xml","form_type":"4"}},{"id":2289737,"issuer":{"id":126356,"kind":"organization","name":"Clarus Therapeutics Holdings, Inc.","symbol":"CRXT"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-27T16:09:13.000Z","date":"2022-04-25","kind":"other","acquired":false,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"see footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the transfer of an aggregate of 65,000 shares of common stock held by Blue Water Sponsor LLC (the \"Sponsor\") to certain affiliates of the Sponsor pursuant to certain share transfer agreements by and between the Sponsor and each transferee."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Joseph Hernandez, a director and former chief executive officer of the registrant, is the managing member of the Sponsor. Accordingly, Mr. Hernandez may be deemed to have beneficial ownership of such shares. Mr. Hernandez disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly."}],"balance_after":1237500,"source":{"system":"sec-edgar","filing":"0001213900-22-021910","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022021910/ownership.xml","form_type":"4"}},{"id":2473643,"issuer":{"id":126356,"kind":"organization","name":"Clarus Therapeutics Holdings, Inc.","symbol":"CRXT"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-14T19:00:39.000Z","date":"2021-12-12","kind":"grant","acquired":true,"shares":9610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options were granted under the 2021 Plan and vest in equal annual installments over a period of three years from the date of grant subject to the Reporting Person having a service relationship as of each such vesting."}],"balance_after":9610,"derivative":{"exercise_price":4.78,"expiration_date":"2031-12-11","underlying":"Common Stock","underlying_shares":9610},"source":{"system":"sec-edgar","filing":"0000899243-21-048205","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1817944/000089924321048205/doc4.xml","form_type":"4"}},{"id":2473642,"issuer":{"id":126356,"kind":"organization","name":"Clarus Therapeutics Holdings, Inc.","symbol":"CRXT"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-14T19:00:39.000Z","date":"2021-12-12","kind":"grant","acquired":true,"shares":3844,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted a Restricted Stock Unit under the Issuer's 2021 Stock Option and Incentive Plan (the \"2021 Plan\") for 3,844 shares on 12/12/2021, which vests in equal annual installments over three years from the date of grant subject to the Reporting Person having a service relationship as of each such vesting date."}],"balance_after":3844,"source":{"system":"sec-edgar","filing":"0000899243-21-048205","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817944/000089924321048205/doc4.xml","form_type":"4"}},{"id":2561046,"issuer":{"id":126356,"kind":"organization","name":"Clarus Therapeutics Holdings, Inc.","symbol":"CRXT"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":135254,"kind":"organization","name":"Blue Water Sponsor LLC","position":2,"cik":"0001818124","reported_name":"Blue Water Sponsor LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}}],"security":"Warrant","published_at":"2021-09-23T16:10:24.000Z","date":"2021-09-09","kind":"grant","acquired":true,"shares":3445000,"price":1,"value":3445000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The Sponsor acquired these warrants for a purchase price of $1.00 per warrant in connection with the initial public offering of the registrant. The warrants could only become eligible for exercise upon consummation of the registrant's initial business combination. Since the exercise of the warrants was contingent upon the closing of the business combination, these warrants were not reported at the time of acquisition. The acquisition is being reported now in connection with the consummation of the registrant's initial business combination."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"As described in the registrant's registration statement on Form S-4 (File No. 333-256116) and the second amended and restated certificate of incorporation of the registrant, which took effect in connection with the closing of the registrant's business combination with Clarus Therapeutics, Inc., a Delaware corporation (\"Clarus\"), on September 9, 2021, all Class A common stock of the registrant was redesignated as common stock, par value $0.0001 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Joseph Hernandez, a director and former chief executive officer of the registrant, is the managing member of the Sponsor. Accordingly, Mr. Hernandez may be deemed to have beneficial ownership of such shares. Mr. Hernandez disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly."}],"balance_after":3445000,"derivative":{"exercise_price":11.5,"exercise_date":"2021-09-09","expiration_date":"2026-09-09","underlying":"Common Stock","underlying_shares":3445000},"source":{"system":"sec-edgar","filing":"0001213900-21-049546","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1818124/000121390021049546/ownership.xml","form_type":"4/A","original_submission_date":"2021-09-13"}},{"id":2561045,"issuer":{"id":126356,"kind":"organization","name":"Clarus Therapeutics Holdings, Inc.","symbol":"CRXT"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":135254,"kind":"organization","name":"Blue Water Sponsor LLC","position":2,"cik":"0001818124","reported_name":"Blue Water Sponsor LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}}],"security":"Class B Common Stock","published_at":"2021-09-23T16:10:24.000Z","date":"2021-09-09","kind":"exercise","acquired":false,"shares":1437500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"As described in the registrant's registration statement on Form S-1 (File No. 333-248569) under the heading \"Description of Securities - Founder Shares,\" the shares of Class B common stock were automatically converted into shares of Class A common stock at the time of the registrant's initial business combination on a one-for-one basis, and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As described in the registrant's registration statement on Form S-1 (File No. 333-248569) under the heading \"Description of Securities - Founder Shares,\" the shares of Class B common stock were automatically converted into shares of Class A common stock at the time of the registrant's initial business combination on a one-for-one basis, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"As described in the registrant's registration statement on Form S-1 (File No. 333-248569) under the heading \"Description of Securities - Founder Shares,\" the shares of Class B common stock were automatically converted into shares of Class A common stock at the time of the registrant's initial business combination on a one-for-one basis, and have no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"As described in the registrant's registration statement on Form S-4 (File No. 333-256116) and the second amended and restated certificate of incorporation of the registrant, which took effect in connection with the closing of the registrant's business combination with Clarus Therapeutics, Inc., a Delaware corporation (\"Clarus\"), on September 9, 2021, all Class A common stock of the registrant was redesignated as common stock, par value $0.0001 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Joseph Hernandez, a director and former chief executive officer of the registrant, is the managing member of the Sponsor. Accordingly, Mr. Hernandez may be deemed to have beneficial ownership of such shares. Mr. Hernandez disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1437500},"source":{"system":"sec-edgar","filing":"0001213900-21-049546","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818124/000121390021049546/ownership.xml","form_type":"4/A","original_submission_date":"2021-09-13"}},{"id":2561044,"issuer":{"id":126356,"kind":"organization","name":"Clarus Therapeutics Holdings, Inc.","symbol":"CRXT"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":135254,"kind":"organization","name":"Blue Water Sponsor LLC","position":2,"cik":"0001818124","reported_name":"Blue Water Sponsor LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}}],"security":"Common Stock","published_at":"2021-09-23T16:10:24.000Z","date":"2021-09-09","kind":"other","acquired":false,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"see footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the transfer of an aggregate of 135,000 shares of common stock held by Blue Water Sponsor LLC (the \"Sponsor\") to certain noteholders of Clarus, pursuant to that certain share allocation agreement, dated as of September 1, 2021, entered by and among Clarus, the registrant, the Sponsor, certain noteholders and equityholders of Clarus."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Joseph Hernandez, a director and former chief executive officer of the registrant, is the managing member of the Sponsor. Accordingly, Mr. Hernandez may be deemed to have beneficial ownership of such shares. Mr. Hernandez disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly."}],"balance_after":1302500,"source":{"system":"sec-edgar","filing":"0001213900-21-049546","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818124/000121390021049546/ownership.xml","form_type":"4/A","original_submission_date":"2021-09-13"}},{"id":2561043,"issuer":{"id":126356,"kind":"organization","name":"Clarus Therapeutics Holdings, Inc.","symbol":"CRXT"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":135254,"kind":"organization","name":"Blue Water Sponsor LLC","position":2,"cik":"0001818124","reported_name":"Blue Water Sponsor LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}}],"security":"Common Stock","published_at":"2021-09-23T16:10:24.000Z","date":"2021-09-09","kind":"exercise","acquired":true,"shares":1437500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"see footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As described in the registrant's registration statement on Form S-1 (File No. 333-248569) under the heading \"Description of Securities - Founder Shares,\" the shares of Class B common stock were automatically converted into shares of Class A common stock at the time of the registrant's initial business combination on a one-for-one basis, and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Joseph Hernandez, a director and former chief executive officer of the registrant, is the managing member of the Sponsor. Accordingly, Mr. Hernandez may be deemed to have beneficial ownership of such shares. Mr. Hernandez disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly."}],"balance_after":1437500,"source":{"system":"sec-edgar","filing":"0001213900-21-049546","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818124/000121390021049546/ownership.xml","form_type":"4/A","original_submission_date":"2021-09-13"}},{"id":2572111,"issuer":{"id":127900,"kind":"organization","name":"CLARUS THERAPEUTICS INC","symbol":"CRXT"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":135254,"kind":"organization","name":"Blue Water Sponsor LLC","position":2,"cik":"0001818124","reported_name":"Blue Water Sponsor LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}}],"security":"Warrant","published_at":"2021-09-13T19:29:02.000Z","date":"2021-09-09","kind":"grant","acquired":true,"shares":3445000,"price":1,"value":3445000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The Sponsor acquired these warrants for a purchase price of $1.00 per warrant in connection with the initial public offering of the registrant. The warrants could only become eligible for exercise upon consummation of the registrant's initial business combination. Since the exercise of the warrants was contingent upon the closing of the business combination, these warrants were not reported at the time of acquisition. The acquisition is being reported now in connection with the consummation of the registrant's initial business combination."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"As described in the registrant's registration statement on Form S-4 (File No. 333-256116) and the second amended and restated certificate of incorporation of the registrant, which took effect in connection with the closing of the registrant's business combination with Clarus Therapeutics, Inc., a Delaware corporation (\"Clarus\"), on September 9, 2021, all Class A common stock of the registrant was redesignated as common stock, par value $0.0001 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Joseph Hernandez, a director and former chief executive officer of the registrant, is the managing member of the Sponsor. Accordingly, Mr. Hernandez may be deemed to have beneficial ownership of such shares. Mr. Hernandez disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly."}],"balance_after":3445000,"derivative":{"exercise_price":11.5,"exercise_date":"2021-09-09","expiration_date":"2026-09-09","underlying":"Common Stock","underlying_shares":3445000},"source":{"system":"sec-edgar","filing":"0001213900-21-047779","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1818124/000121390021047779/ownership.xml","form_type":"4"}},{"id":2572110,"issuer":{"id":127900,"kind":"organization","name":"CLARUS THERAPEUTICS INC","symbol":"CRXT"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":135254,"kind":"organization","name":"Blue Water Sponsor LLC","position":2,"cik":"0001818124","reported_name":"Blue Water Sponsor LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}}],"security":"Class B Common Stock","published_at":"2021-09-13T19:29:02.000Z","date":"2021-09-09","kind":"exercise","acquired":false,"shares":1437500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"As described in the registrant's registration statement on Form S-1 (File No. 333-248569) under the heading \"Description of Securities - Founder Shares,\" the shares of Class B common stock were automatically converted into shares of Class A common stock at the time of the registrant's initial business combination on a one-for-one basis, and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As described in the registrant's registration statement on Form S-1 (File No. 333-248569) under the heading \"Description of Securities - Founder Shares,\" the shares of Class B common stock were automatically converted into shares of Class A common stock at the time of the registrant's initial business combination on a one-for-one basis, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"As described in the registrant's registration statement on Form S-1 (File No. 333-248569) under the heading \"Description of Securities - Founder Shares,\" the shares of Class B common stock were automatically converted into shares of Class A common stock at the time of the registrant's initial business combination on a one-for-one basis, and have no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"As described in the registrant's registration statement on Form S-4 (File No. 333-256116) and the second amended and restated certificate of incorporation of the registrant, which took effect in connection with the closing of the registrant's business combination with Clarus Therapeutics, Inc., a Delaware corporation (\"Clarus\"), on September 9, 2021, all Class A common stock of the registrant was redesignated as common stock, par value $0.0001 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Joseph Hernandez, a director and former chief executive officer of the registrant, is the managing member of the Sponsor. Accordingly, Mr. Hernandez may be deemed to have beneficial ownership of such shares. Mr. Hernandez disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1437500},"source":{"system":"sec-edgar","filing":"0001213900-21-047779","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818124/000121390021047779/ownership.xml","form_type":"4"}},{"id":2572109,"issuer":{"id":127900,"kind":"organization","name":"CLARUS THERAPEUTICS INC","symbol":"CRXT"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":135254,"kind":"organization","name":"Blue Water Sponsor LLC","position":2,"cik":"0001818124","reported_name":"Blue Water Sponsor LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}}],"security":"Common Stock","published_at":"2021-09-13T19:29:02.000Z","date":"2021-09-09","kind":"other","acquired":false,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"see footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the transfer of an aggregate of 135,000 shares of common stock held by Blue Water Sponsor LLC (the \"Sponsor\") to certain noteholders of Clarus, pursuant to that certain share allocation agreement, dated as of September 1, 2021, entered by and among Clarus, the registrant, the Sponsor, certain noteholders and equityholders of Clarus."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Joseph Hernandez, a director and former chief executive officer of the registrant, is the managing member of the Sponsor. Accordingly, Mr. Hernandez may be deemed to have beneficial ownership of such shares. Mr. Hernandez disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly."}],"balance_after":1302500,"source":{"system":"sec-edgar","filing":"0001213900-21-047779","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818124/000121390021047779/ownership.xml","form_type":"4"}},{"id":2572108,"issuer":{"id":127900,"kind":"organization","name":"CLARUS THERAPEUTICS INC","symbol":"CRXT"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":135254,"kind":"organization","name":"Blue Water Sponsor LLC","position":2,"cik":"0001818124","reported_name":"Blue Water Sponsor LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}}],"security":"Common Stock","published_at":"2021-09-13T19:29:02.000Z","date":"2021-09-09","kind":"exercise","acquired":true,"shares":1437500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"see footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As described in the registrant's registration statement on Form S-1 (File No. 333-248569) under the heading \"Description of Securities - Founder Shares,\" the shares of Class B common stock were automatically converted into shares of Class A common stock at the time of the registrant's initial business combination on a one-for-one basis, and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Joseph Hernandez, a director and former chief executive officer of the registrant, is the managing member of the Sponsor. Accordingly, Mr. Hernandez may be deemed to have beneficial ownership of such shares. Mr. Hernandez disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly."}],"balance_after":1437500,"source":{"system":"sec-edgar","filing":"0001213900-21-047779","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818124/000121390021047779/ownership.xml","form_type":"4"}},{"id":2895661,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $.001 par value","published_at":"2021-01-26T22:12:48.000Z","date":"2021-01-14","kind":"sale","acquired":false,"shares":870854,"price":0.9835,"value":856484.909,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person sold these shares of common stock on the open market."},{"field":"shares","element":"transactionShares","label":"F2","text":"On May 1, 2020, the reporting person received 9,200,000 shares of Oragenics, Inc. through a Stock Purchase Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This reflects the weighted average sale price. On January 14, 2021, the reporting person sold a total of 870,854 shares for a total of $859,466.01 on the open market, with the range of prices for such transactions being $0.9602 to $0.1.0068 per share. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-21-004433","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000121390021004433/ownership.xml","form_type":"4"}},{"id":2895660,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $.001 par value","published_at":"2021-01-26T22:12:48.000Z","date":"2021-01-13","kind":"sale","acquired":false,"shares":257510,"price":0.8,"value":206008.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person sold these shares of common stock on the open market."},{"field":"shares","element":"transactionShares","label":"F2","text":"On May 1, 2020, the reporting person received 9,200,000 shares of Oragenics, Inc. through a Stock Purchase Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"On January 13, 2021, the reporting person sold 257,510 shares on the open market at $0.8000 per share, the market price of the common stock on such date, for total proceeds of $205,994.44."}],"balance_after":870854,"source":{"system":"sec-edgar","filing":"0001213900-21-004433","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000121390021004433/ownership.xml","form_type":"4"}},{"id":2895659,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $.001 par value","published_at":"2021-01-26T22:12:48.000Z","date":"2021-01-12","kind":"sale","acquired":false,"shares":629707,"price":0.7308,"value":460189.8756,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person sold these shares of common stock on the open market."},{"field":"shares","element":"transactionShares","label":"F2","text":"On May 1, 2020, the reporting person received 9,200,000 shares of Oragenics, Inc. through a Stock Purchase Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This reflects the weighted average sale price. On January 11, 2021, the reporting person sold a total of 629,707 shares for a total of $455,441.30 on the open market, with the range of prices for such transactions being $0.7201 to $0.7501 per share. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1128364,"source":{"system":"sec-edgar","filing":"0001213900-21-004433","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000121390021004433/ownership.xml","form_type":"4"}},{"id":2895658,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $.001 par value","published_at":"2021-01-26T22:12:48.000Z","date":"2021-01-11","kind":"sale","acquired":false,"shares":441929,"price":0.771,"value":340727.259,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person sold these shares of common stock on the open market."},{"field":"shares","element":"transactionShares","label":"F2","text":"On May 1, 2020, the reporting person received 9,200,000 shares of Oragenics, Inc. through a Stock Purchase Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"On January 11, 2021, the reporting person sold 441,929 shares on the open market at $0.7710 per share, the market price of the common stock on such date, for total proceeds of $340,710.72."}],"balance_after":1758071,"source":{"system":"sec-edgar","filing":"0001213900-21-004433","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000121390021004433/ownership.xml","form_type":"4"}},{"id":2895657,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $.001 par value","published_at":"2021-01-26T22:12:48.000Z","date":"2021-01-07","kind":"sale","acquired":false,"shares":323997,"price":0.84,"value":272157.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person sold these shares of common stock on the open market."},{"field":"shares","element":"transactionShares","label":"F2","text":"On May 1, 2020, the reporting person received 9,200,000 shares of Oragenics, Inc. through a Stock Purchase Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On January 7, 2021, the reporting person sold 323,997 shares on the open market at $0.84 per share, the market price of the common stock on such date, for total proceeds of $272,157.48."}],"balance_after":2200000,"source":{"system":"sec-edgar","filing":"0001213900-21-004433","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000121390021004433/ownership.xml","form_type":"4"}},{"id":2895656,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $.001 par value","published_at":"2021-01-26T22:12:48.000Z","date":"2021-01-06","kind":"sale","acquired":false,"shares":1000000,"price":0.6,"value":600000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person sold these shares of common stock on the open market."},{"field":"shares","element":"transactionShares","label":"F2","text":"On May 1, 2020, the reporting person received 9,200,000 shares of Oragenics, Inc. through a Stock Purchase Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This reflects the weighted average sale price. On January 6, 2021, the reporting person sold a total of 1,000,000 shares for a total of $645,000 on the open market, with the range of prices for such transactions being $0.60 to $0.73 per share. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2523997,"source":{"system":"sec-edgar","filing":"0001213900-21-004433","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000121390021004433/ownership.xml","form_type":"4"}},{"id":2895655,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $.001 par value","published_at":"2021-01-26T22:12:48.000Z","date":"2021-01-05","kind":"sale","acquired":false,"shares":500000,"price":0.5804,"value":290200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person sold these shares of common stock on the open market."},{"field":"shares","element":"transactionShares","label":"F2","text":"On May 1, 2020, the reporting person received 9,200,000 shares of Oragenics, Inc. through a Stock Purchase Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On January 5, 2021, the reporting person sold 500,000 shares on the open market at $0.5804 per share, the market price of the common stock on such date, for total proceeds of $290,184.58."}],"balance_after":3523997,"source":{"system":"sec-edgar","filing":"0001213900-21-004433","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000121390021004433/ownership.xml","form_type":"4"}},{"id":2895654,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $.001 par value","published_at":"2021-01-26T22:12:48.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":176003,"price":0.52,"value":91521.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person sold these shares of common stock on the open market."},{"field":"shares","element":"transactionShares","label":"F2","text":"On May 1, 2020, the reporting person received 9,200,000 shares of Oragenics, Inc. through a Stock Purchase Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On January 4, 2021, the reporting person sold 176,003 shares on the open market at $0.52 per share, the market price of the common stock on such date, for total proceeds of $91,521.56."}],"balance_after":4023997,"source":{"system":"sec-edgar","filing":"0001213900-21-004433","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000121390021004433/ownership.xml","form_type":"4"}},{"id":2955385,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $.001 par value","published_at":"2020-12-07T11:18:43.000Z","date":"2020-12-02","kind":"sale","acquired":false,"shares":5000000,"price":0.4103,"value":2051500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 1, 2020, the reporting person received 9,200,000 shares of Oragenics, Inc. through a Stock Purchase Agreement. On December 2, 2020, the reporting person sold 5,000,000 of those shares on the open market at $0.4103 per share for total proceeds of $2,051,445.66, the market price of the common stock on such date."}],"balance_after":4200000,"source":{"system":"sec-edgar","filing":"0001213900-20-041200","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000121390020041200/ownership.xml","form_type":"4"}}]}